2018-10-11T14:11:54-05:00 2017-12-31 521855942 TATE AND TRYON 2021 L STREET NW SUITE 400 WASHINGTON DC 20036 990 2017-01-01 526039142 AMERICAN PHARMACISTS ASSOCIATION FOUNDATION AMER 2026284410 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 ELIZABETH KEYES EXECUTIVE DIRECTOR 2026284410 2018-10-11 1 DEBORAH G KOSNETT P00290720 2022932200 2018-10-05 216.59.105.130 2018-10-11 14:11:51 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 E907A8F149D67D06177CCD6DEBFA17496A4235B9 2017 2018-06-14 16:35:46Z APHA FOUNDATION ELIZABETH KEYES 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 2591855 0 X WWW.APHAFOUNDATION.ORG X 1953 DC THE MISSION OF THE APHA FOUNDATION IS TO IMPROVE HEALTH BY INSPIRING PHILANTHROPY, RESEARCH AND INNOVATION THAT ADVANCES PHARMACISTS' PATIENT CARE SERVICES. THE APHA FOUNDATION LOOKS TO CREATE A NEW MEDICATION USE SYSTEM WHERE PATIENTS, PHARMACISTS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS COLLABORATE TO DRAMATICALLY IMPROVE THE COST EFFECTIVENESS AND QUALITY OF PATIENT HEALTH OUTCOMES. 9 8 0 50 0 0 1337181 1436601 34704 44162 75212 249856 10797 18175 1457894 1748794 69599 48073 0 0 551523 674061 0 0 290846 1072868 918519 1693990 1640653 -236096 108141 5812188 6007046 1435110 1328242 4377078 4678804 X THE MISSION OF THE APHA FOUNDATION IS TO IMPROVE HEALTH BY INSPIRING PHILANTHROPY, RESEARCH AND INNOVATION THAT ADVANCES PHARMACISTS' PATIENT CARE SERVICES. THE APHA FOUNDATION LOOKS TO CREATE A NEW MEDICATION USE SYSTEM WHERE PATIENTS, PHARMACISTS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS COLLABORATE TO DRAMATICALLY IMPROVE THE COST EFFECTIVENESS AND QUALITY OF PATIENT HEALTH OUTCOMES. 0 0 822811 44162 SCIENCE AND RESEARCH - OUR RESEARCH PROJECTS ESTABLISH NEW MODELS OF PRACTICE FOR PHARMACISTS AND REDEFINE PATIENTS' HEALTHCARE EXPERIENCE. WE CONNECT EACH PATIENT TO A PHARMACIST WHO EMPOWERS THEM TO BECOME SUCCESSFUL IN MANAGING HIS OR HER OWN HEALTH. OUR WORK VALIDATED THAT THE PHARMACISTS ARE ESSENTIAL TO HELPING PATIENTS ACHIEVE BETTER HEALTH OUTCOMES. THE FOUNDATION RESEARCH PROJECTS INCLUDE IMMUNIZATION REGISTRIES, BEATING DIABETES, DIABETES PATIENT CREDENTIALING, DIABETES PREVENTION, AND IMPACT INSTITUTE. 135591 48073 AWARDS AND GRANTS - TO ENCOURAGE THE ENHANCEMENT OF PHARMACISTS' SKILLS AND TO PROVIDE BETTER SERVICE TO THE PUBLIC IN THE AREA OF PHARMACEUTICAL CARE. THE FOUNDATION HAS THREE AWARD PROGRAMS: 1) INCENTIVE GRANTS - PROVIDES SEED FUNDING TO PHARMACISTS WHO WANT TO ESTABLISH OR SUPPORT ALREADY EXISTING PATIENT CARE SERVICES WITHIN THEIR PHARMACY PRACTICE. 2) PINNACLE AWARDS - ANNUAL RECOGNITION PROGRAM FOR CONTRIBUTIONS TO HEALTHCARE QUALITY THROUGH THE MEDICATION USE PROCESS. 3) STUDENT SCHOLARSHIP PROGRAM - RECOGNIZES STUDENTS WHO HELP SHAPE THE FUTURE OF THE PROFESSION. 958402 1 1 0 0 0 0 0 1 0 1 1 0 0 0 1 0 1 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 15 0 1 0 0 0 0 0 0 1 1 0 0 0 0 X 9 8 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X AMERICAN PHARMACISTS ASSOCIATION 2026284410 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 LEONARD EDLOE PRESIDENT 2.00 0.00 X X 0 0 0 STEVE SIMENSON VICE PRESIDENT 2.00 0.00 X X 0 0 0 TIM CANNING TREASURER 2.00 0.00 X X 0 0 0 THOMAS MENIGHAN SECRETARY 2.00 0.00 X X 0 647841 74211 MEGAN TUCKER DIRECTOR 2.00 0.00 X 0 0 0 ELEANOR VOGT DIRECTOR 2.00 0.00 X 1000 0 0 ED HAMILTON DIRECTOR 2.00 0.00 X 0 0 0 LAURA CARPENTER DIRECTOR 2.00 0.00 X 0 0 0 TROY TRYGSTAD DIRECTOR 2.00 0.00 X 0 0 0 KELLY VALENTE THRU 317 DIRECTOR 2.00 0.00 X 0 0 0 JERRY MOORE THRU 317 DIRECTOR 2.00 0.00 X 0 0 0 ELIZABETH KEYES EXECUTIVE DIRECTOR 3.50 36.50 X 54000 292460 37588 BENJAMIN BLUML SENIOR VICE PRESIDENT OF RESEARCH 40.00 0.00 X 183584 0 31635 MARY MCMAHON DIRECTOR OF DEVELOPMENT 40.00 0.00 X 112693 0 14309 351277 940301 157743 2 0 1 1 0 121247 1315354 1436601 IQ WARE PROGRAM 541900 44162 44162 44162 115978 115978 940817 806939 133878 133878 133878 51263 36122 15141 15141 MISCELLANEOUS INCOME 900099 3034 3034 3034 1748794 44162 0 268031 X 48073 48073 269218 238425 15476 15317 335658 59983 108635 167040 6106 3000 3106 20022 3723 16299 43057 18497 12351 12209 36067 24775 11292 15341 15341 18234 18234 463620 430883 27757 4980 41543 5541 18818 17184 58684 33595 14481 10608 45400 31036 2879 11485 68941 24133 42222 2586 19342 19342 OVERHEAD 65004 65004 OTHER EXPENSE 63212 59355 192 3665 BAD DEBT EXPENSE 11853 778 -1250 12325 PROFESSIONAL DUES & SUB 11278 8103 425 2750 1640653 958402 391405 290846 610251 942382 983384 1089258 30831 162859 5314 1059 387703 271882 181389 115821 4001019 3695667 5812188 6007046 375825 177927 476350 187803 582935 962512 1435110 1328242 X 1363982 1215521 1388258 1560242 1624838 1903041 4377078 4678804 5812188 6007046 108141 193585 0 X X 0 1 X 1 0 X 2561997 1339709 928851 1337181 1436601 7604339 2561997 1339709 928851 1337181 1436601 7604339 3784150 3820189 97522 152382 132691 108549 115978 607122 7434 15141 22575 3363 3034 6397 8240433 181020 0.46360 0.45320 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS X 0 2044251 307429 342056 86911 2606825 1227804 766849 133558 83960 2044251 1278879 37480 -18415 70140 1227804 1072550 232421 44832 70924 1278879 825498 225573 116763 95284 1072550 0.00000 0.73000 0.27000 0 0 327476 250859 76617 60227 21023 39204 115821 DUE TO AFFILIATE 962512 962512 1960266 193585 36121 229706 1730560 18234 18234 1748794 1658540 36121 36121 1622419 18234 18234 1640653 PART III, LINE 1A: THE FOUNDATION ACQUIRED AN ART COLLECTION WITH AN APPRAISED VALUE OF APPROXIMATELY $1,300,000 THROUGH A DONOR CONTRIBUTION IN A PRIOR YEAR. THE COLLECTION WAS RECEIVED WITH A PERMANENT DONOR RESTRICTION THAT THE COLLECTION CANNOT AND SHOULD NOT BE SOLD. IN 2009, THE FOUNDATION COMMISSIONED TWO BRONZE SCULPTURES WHICH DEPICT THE ROLES OF PHARMACISTS. THE COST TO CREATE THESE SCULPTURES WAS APPROXIMATELY $120,000. THE FOUNDATION'S COLLECTIONS ARE HELD FOR PUBLIC EXHIBITION, ARE CARED FOR AND PRESERVED, AND PROCEEDS FROM DE-ACCESSIONS OR INSURANCE RECOVERIES FOR LOST OR DAMAGED COLLECTION ITEMS ARE DESIGNATED FOR FUTURE COLLECTION ACQUISITIONS. UNDER AUTHORITATIVE GUIDANCE ISSUED BY THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB), THE FOUNDATION HAS THE OPTION OF NOT CAPITALIZING ITS COLLECTIONS. THE FOUNDATION HAS ELECTED NOT TO CAPITALIZE ITS COLLECTIONS, AND ACCORDINGLY, THESE COLLECTIONS ARE NOT RECOGNIZED AS ASSETS IN THE ACCOMPANYING STATEMENTS OF FINANCIAL POSITION. PURCHASE OF COLLECTION ITEMS ARE RECOGNIZED AS REDUCTION IN UNRESTRICTED NET ASSETS IN THE PERIOD OF ACQUISITION. PART III, LINE 4: THE ART COLLECTION, TITLED "GREAT MOMENTS IN PHARMACY," PROVIDES A PICTORIAL HISTORY OF PHARMACY FROM EARLY CIVILIZATION UNTIL THE 1950'S THROUGH A SERIES OF 40 PAINTINGS PAINTED BY THE ARTIST ROBERT THOM. THE FOUNDATION'S ARTICLES OF INCORPORATION STATE THAT "THE PARTICULAR BUSINESS AND OBJECTS OF SAID CORPORATION SHALL BE TO RECEIVE GIFTS, BEQUESTS AND DEVICES OR PROPERTY AND OTHERWISE TO ACQUIRE PROPERTY, REAL AND PERSONAL, OF WHATSOEVER NATURE AND WHERESOEVER THE SAME MAY BE SITUATE TO BE USED EXCLUSIVELY FOR THE ADVANCEMENT OF THE SCIENCE OF PHARMACY AND PHARMACEUTICAL EDUCATION...". THE DISPLAY OF THIS COLLECTION FURTHERS THE FOUNDATION'S EDUCATIONAL PURPOSES AS IT IS AVAILABLE TO ALL VISITORS TO THE BUILDINGS. REPRODUCTION RIGHTS TO THE IMAGES HAVE BEEN GRANTED FOR USE IN TEXT BOOKS AND OTHER SCHOLARLY BOOKS. PART V, LINE 4: THE FOUNDATION'S PERMANENTLY RESTRICTED NET ASSETS ARE USED TO GENERATE REVENUE TO SUPPORT THE ONGOING MANAGEMENT AND ADMINISTRATION OF PROGRAMS. PART XI, LINE 2D - OTHER ADJUSTMENTS: RECLASS EVENT EXPENSE TO PART VIII 36,121. PART XII, LINE 2D - OTHER ADJUSTMENTS: RECLASS EVENT EXPENSE TO PART VIII 36,121. WINE TASTING/AUCTION 24788 24788 7145 1250 14522 1482 MIX, MINGLE & MARGARITA 16475 16475 1025 5555 1 10000 10000 1121 4022 51263 51263 7145 3396 14522 11059 36122 15141 1 HONORARIUM AND AWARDS 8 12650 INCENTIVE GRANTS 18 19000 SCHOLARSHIPS 15 16423 PART I, LINE 2: SCHOLARSHIPS AND/OR GRANTS ARE AWARDED BASED ON MERIT. APPLICATIONS ARE APPROVED BY THE BOARD OF DIRECTORS. X X X X 0 0 0 0 0 0 0 0 0 THOMAS MENIGHAN SECRETARY 0 558342 0 52929 0 36570 0 38500 0 35711 0 722052 0 52929 ELIZABETH KEYES EXECUTIVE DIRECTOR 54000 259778 0 13965 0 18717 0 13500 0 24088 54000 330048 0 13965 BENJAMIN BLUML SENIOR VICE PRESIDENT OF RESEARCH 180794 0 1500 0 1290 0 9304 0 22332 0 215220 0 0 0 FORM 990, PART VII, SECTION A, LINE 5: ELIZABETH KEYES RECEIVED A PORTION OF HER COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION FOUNDATION, BUT RECEIVED MOST OF HER COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION, AN UNRELATED AFFILIATE, FOR SERVICES THAT SHE RENDERED TO THE FOUNDATION AS EXECUTIVE DIRECTOR. KEYES RECEIVED $292,460 IN TAXABLE COMPENSATION AND $37,588 IN NONTAXABLE COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION. FORM 990, PART VII, SECTION A, LINE 5: THOMAS MENIGHAN RECEIVED COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION, AN UNRELATED AFFILIATE. MENIGHAN RECEIVED $647,841 IN TAXABLE COMPENSATION AND $74,211 IN NONTAXABLE COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERS OF THE FOUNDATION ARE THE BOARD OF DIRECTORS OF THE FOUNDATION AND THE MEMBERS OF THE BOARD OF TRUSTEES OF THE AMERICAN PHARMACISTS ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 7A THE FOUNDATION'S BOARD SHALL BE APPOINTED BY THE MEMBERS OF THE BOARD OF TRUSTEES OF THE AMERICAN PHARMACISTS ASSOCIATION. FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS REVIEWS THE FORM 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS REVIEWED AND SIGNED BY ALL THE BOARD OF DIRECTORS ANNUALLY. THE FOUNDATION EXECUTIVE DIRECTOR REVIEWS ANY BUSINESS TRANSACTIONS (COMPENSATION/SERVICES RENDERED) WITH BOARD MEMBERS AND THIS INFORMATION, IF ANY, IS DISCLOSED TO THE FOUNDATION'S LEGAL COUNSEL. LEGAL COUNSEL DISCLOSES THIS INFORMATION DURING THE EXECUTIVE SESSION REVIEW OF THE BOARD OF DIRECTORS MEETINGS. FORM 990, PART VI, SECTION B, LINE 15A TOP MANAGEMENT OFFICIAL: THE FOUNDATION BOARD OF DIRECTORS APPROVES THE TOP MANAGEMENT OFFICIAL'S EMPLOYMENT CONTRACT. THE COMPENSATION IN THE EMPLOYMENT CONTRACT WAS DETERMINED THROUGH COMPARABILITY ANALYSIS CONDUCTED BY AN INDEPENDENT CONSULTANT. OTHER OFFICERS AND KEY EMPLOYEES: COMPENSATION IS DETERMINED THROUGH A YEARLY COMPARABILITY ANALYSIS CONDUCTED BY AN INDEPENDENT CONSULTANT (OR IN THOSE INSTANCES WHEN VACANCIES OCCUR). COMPENSATION INCREASES ARE APPROVED BY THE FOUNDATION CEO. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS ARTICLES OF INCORPORATION, BYLAWS, CONFLICT OF INTEREST POLICY, AND AUDITED FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING FEES: PROGRAM SERVICE EXPENSES 430,883. MANAGEMENT AND GENERAL EXPENSES 27,757. FUNDRAISING EXPENSES 4,980. TOTAL EXPENSES 463,620. FORM 990, PART XII, LINE 2C OVERSIGHT OF AUDIT HAS NOT CHANGED FROM PRIOR YEAR.